All Posts Archives - EverGlade

All Posts

BARDA RRPV RAPID Solicitation Rapid Antibody Production

BARDA’s RRPV 26-10-RAPID Solicitation for Rapid Antibody Production

Leave a Comment / All Posts, BARDA, Life Sciences / By

RRPV-26-10-RAPID The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a new Request for Project Proposals (RPP) to stand up U.S.-based rapid antibody and protein binder production platforms that can go from pathogen gene sequence to immunoassay-ready reagents within weeks instead of months. This is a targeted opportunity to position platform […]

BARDA’s RRPV 26-10-RAPID Solicitation for Rapid Antibody Production Read More »

MCDC Host-Directed Therapeutics Initiative

MCDC’s Host-Directed Therapeutics Initiative

Leave a Comment / All Posts / By

The Medical Chemical, Biological, Radiological, and Nuclear Defense Consortium (MCDC), managed by Advanced Technology International (ATI), has issued a Request for Information (RFI) focused on “Host-Directed Medical Countermeasures.” This effort, led in support of the Capability Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND), represents an early step toward shaping a

MCDC’s Host-Directed Therapeutics Initiative Read More »

MCDC Prophylaxis Military Protection

MCDC Seeks Industry Input on Prophylaxis in Advanced Development for Military Biological Threat Protection

Leave a Comment / All Posts / By

The Medical CBRN Defense Consortium (MCDC), through Advanced Technology International (ATI), has issued a Request for Information (RFI) on behalf of the Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) for “Prophylaxis in Advanced Development.” This notice is intended strictly for information gathering and planning and does not constitute a Request

MCDC Seeks Industry Input on Prophylaxis in Advanced Development for Military Biological Threat Protection Read More »

Genesis Mission Everglade Insight

Strategic Deep Dive into the Genesis Mission and What It Means for Government Contractors

Leave a Comment / All Posts / By

The White House’s Genesis Mission, first announced in 2025, represents a foundational shift in how the federal government approaches science, engineering, and advanced technology systems at scale. While the initial announcement positioned the mission as a national call to action, its real significance has become clearer over time. Genesis is less a standalone initiative and

Strategic Deep Dive into the Genesis Mission and What It Means for Government Contractors Read More »

ARPA-H Delphi Program Draft Featured Image

ARPA-H’s Delphi Program Draft ISO Signals New Opportunities in Continuous Biosensing

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ARPA-H-SOL-26-153+DRAFT+Delphi+ISO Overview of the DELPHI Program The Advanced Research Projects Agency for Health (ARPA-H) has released a Draft Innovative Solutions Opening (ISO) for the Delphi program through its Resilient Systems Office (RSO). The draft announcement, ARPA-H-SOL-26-153, is intended to inform the research community about an upcoming funding opportunity and allow potential performers time to prepare

ARPA-H’s Delphi Program Draft ISO Signals New Opportunities in Continuous Biosensing Read More »

ARPA-H ADVOCATE Program

ARPA-H’s ADVOCATE Program: What Amendment 02 Means for Proposers

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ADVOCATEISO_ARPA-H-SOL-26-142_Amendment02 The Advanced Research Projects Agency for Health (ARPA-H) released Amendment 02 to its ADVOCATE solicitation (ARPA-H-SOL-26-142), refining technical expectations, evaluation criteria, and program execution details for one of its most ambitious artificial intelligence initiatives in healthcare. ADVOCATE is designed to accelerate the development, evaluation, and scalable deployment of clinical artificial intelligence (AI) agents that

ARPA-H’s ADVOCATE Program: What Amendment 02 Means for Proposers Read More »

ARPA-H CIRCLE Program

ARPA-H’s CIRCLE Program

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ISO+Amd+1+-+CIRCLE The Advanced Research Projects Agency for Health (ARPA-H), through its Resilient Systems Office (RSO), has released an Innovative Solutions Opening (ISO) titled Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE), ARPA-H-SOL-26-139 . This solicitation reflects ARPA-H’s mandate to pursue bold, high-impact biomedical innovations that can transform patient outcomes at scale. With CIRCLE,

ARPA-H’s CIRCLE Program Read More »

ASPR’s Strategic Plan for FY 2026-2029

Leave a Comment / All Posts, BARDA, Life Sciences / By

Dowload ASPR Strategic Plan FY 2026-2029 The Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) has released its Strategic Plan for Fiscal Years (FY) 2026–2029, setting a clear direction for the federal government’s approach to health security. As the nation’s lead health security agency, ASPR is responsible for preparing

ASPR’s Strategic Plan for FY 2026-2029 Read More »

Medicine capsules global health with geometric pattern digital r

ARPA-H’s Proactive Health Office ISO

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

PROACTIVE HEALTH OFFICE – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) – ARPA-H-SOL-24-106 – Amendment 03: October 14, 2025 Building a Healthier Future Through Prevention The Advanced Research Projects Agency for Health (ARPA-H), a key innovation agency within the U.S. Department of Health and Human Services, has released an updated solicitation for its Proactive Health Office

ARPA-H’s Proactive Health Office ISO Read More »

US_UK Technology Prosperity Deal

The U.S.–U.K. Technology Prosperity Deal: A Strategic Framework for Shared Innovation

Leave a Comment / All Posts, Emerging Technologies / By

On September 18, 2025, the Governments of the United States and the United Kingdom signed a Memorandum of Understanding Between the Government of the United States of America and the Government of the United Kingdom of Great Britain and Northern Ireland Regarding the Technology Prosperity Deal. This MOU reflects both countries’ commitment to partnering on

The U.S.–U.K. Technology Prosperity Deal: A Strategic Framework for Shared Innovation Read More »

Enzyme structure with biological concept 3d rendering

BARDA Solicits Enzymatic Debridement Solutions

Leave a Comment / All Posts, BARDA, Life Sciences / By

BARDA RFP – Enzymatic Debridement Products for Treatments of Deep and Full- Thickness Severe Burn Injuries – 75A50125R00007 – Amendment 0001 The Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services (HHS), has released a significant new opportunity to strengthen national preparedness for burn mass casualty

BARDA Solicits Enzymatic Debridement Solutions Read More »

Blue digitally distorted brain illustration

ARPA-H Announces the Functional Repair of Neocortical Tissue (FRONT) Program

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Functional Repair of Neocortical Tissue (FRONT) Health Science Futures (HSF) Innovative Solutions Opening (ISO) ARPA-H-SOL-25-120 July 10, 2025 Restoring the Damaged Brain: ARPA-H’s FRONT Program Targets Functional Neocortical Repair The Advanced Research Projects Agency for Health (ARPA-H) has announced an ambitious new program under its Health Science Futures (HSF) office: the Functional Repair of Neocortical

ARPA-H Announces the Functional Repair of Neocortical Tissue (FRONT) Program Read More »

Scroll to Top